Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

Clinical trial NCT02781883 · RECRUITING

Trial details

NCT number: NCT02781883
Sponsor: Bio-Path Holdings, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)

Start date: 2016-05-01
Primary completion: 2027-12-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.